Optimizing Surgical Decisions in Young Adults With Breast Cancer
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 44 Years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Questionnaires, Interviews
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Participants will complete surveys approximately within 1 week of the surgical consult and approximately 6 months after surgery."
- "Some patients will be invited for an interview after their surgery as part of the evaluation."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at whether a website tool called CONSYDER helps young women newly diagnosed with breast cancer make surgery decisions. The tool shares information and aims to help women talk with their surgeons. Participants will fill out surveys, and some may have an interview or have their surgery visit audio-recorded.
The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions. Participants will complete surveys approximately within 1 week of the surgical consult and approximately 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients/surgeons will also have their surgical consultation audio-recorded.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Women ages 18–44.
- Newly diagnosed with stage 0, 1, 2, or 3 breast cancer in only one breast.
- Speak English or Spanish.
Who can't join
- Stage 4 breast cancer when first diagnosed, meaning it has spread to distant parts of the body.
- Early-stage breast cancer that has come back.
- Cancer in both breasts.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Female aged 18-44 * New diagnosis of Stage 0, 1, 2, or 3 unilateral breast cancer * English or Spanish speaking Exclusion Criteria: * Diagnosis of de novo Stage 4 breast cancer * Recurrent early-stage breast cancer * Bilateral breast cancer
Study sites (4)
CT
- Yale Cancer Center · New Haven, CT 06510Rachel Greenup, MD, MPH · Study contact · 203-737-2966 · rachel.greenup@yale.eduRachel Greenup, MD, MPH · Principal investigatorMore trials in New Haven
MA
- Dana-Farber Cancer Institute · Boston, MA 02215Ann Partridge, MD, MPH · Study contact · 617-632-3800 · ann_partridge@dfci.harvard.eduAnn Partridge, MD, MPH · Principal investigatorMore trials in Boston
NC
- Duke Cancer Institute · Durham, NC 27710Jennifer Plichta, MD, MS · Study contact · 9196819156 · jennifer.plichta@duke.eduJennifer Plichta, MD, MS · Principal investigatorMore trials in Durham
NY
- Weill Cornell Medicine · New York, NY 10065Shoshana Rosenberg, ScD, MPH · Study contact · 646-962-8041 · shr4009@med.cornell.eduDarima Dorzhieva · Study contact · 646-962-8666 · dad4011@med.cornell.eduShoshana Rosenberg, ScD, MPH · Principal investigatorMore trials in New York